.

Picomole’s breath analysis technology is a robust and versatile test platform for clinical applications requiring accuracy and sensitivity, including the early diagnosis and management of breast cancer, lung cancer, liver disease and kidney disease. The early detection of these diseases is a real challenge for conventional tests, and yet the importance cannot be understated. Early detection frequently means the difference between timely, effective treatment today and costly medical interventions in the future.

Other Applications

Picomole’s breath analysis technology can detect most of the breath biomarkers associated with the following diseases/conditions that have been reported in the peer-reviewed scientific literature:

• Angina
• Asthma
• Bladder Cancer
• Chronic Pulmonary Obstructive Disease
• Colorectal Cancer
• Diabetes
• Gastric/Stomach Cancer
• Meningitis
• Oral Malodor
• Pancreatic Cancer
• Periodontitis
• Schizophrenia
• Smoking
• Substance Abuse
• Tuberculosis

Click here to learn how you can work with us to develop applications.